Search

C16H12ClFO5, monclinic, P21/c (no. 14), a = 14.7536(6) Å, b = 7.8281(3) Å, c = 14.0501(7) Å, β = 111.174 ( 5 ) ° $111.174(5){}^{\circ}$ , V = 1513.13(12) Å3, Z = 4, R gt (F) = 0.0367, wR ref (F 2) = 0.0865, T = 296(2) K.

[C10H11N2 +, PF6 −], triclinic, P 1 ‾ $P\overline{1}$ (no. 2), a = 8.9854(3) Å, b = 9.1004(3) Å, c = 9.2312(3) Å, α = 66.667(3)°, β = 74.875(3)°, γ = 74.024(3)°, V = 656.40(4) Å3, Z = 2, Rgt (F) = 0.0513, wRref (F 2) = 0.1515, T = 296(2) K.

[C11H10O5], monoclinic, P21/n, a = 7.041(3) Å, b = 9.339(4) Å, c = 15.614(6) Å, β = 103.03°, V = 1000.2(7) Å3, Z = 4, Rgt (F) = 0.0337, wR ref (F 2) = 0.0994, T = 296(2) K.

C9H11BrNiO8, monoclinic, P21/c (no. 14), a = 8.5077(16) Å, b = 6.7688(13) Å, c = 22.459(4) Å, β = 98.188(2)°, V = 1280.2(4) Å3, Z = 4, R gt(F) = 0.0256, wR ref(F 2) = 0.0585, T = 296(2) K.

C32H56F24N8P4, triclinic, P 1 ‾ $P‾{1}$ (no. 2), a = 8.6769(13) Å, b = 9.8858(14) Å, c = 14.510(2) Å, α = 102.564(2)°, β = 94.461(3)°, γ = 92.152(3)°, V = 81.710(2) Å3, Z = 1, R gt (F) = 0.0692, wR ref (F 2) = 0.2245, T = 296(2) K.

C12H12O4, monoclinic, P21/c (no. 14), a = 16.071(6) Å, b = 9.424(4) Å, c = 7.640(3) Å, β = 101.861(5)°, V = 1132.4(8) Å3, Z = 4, R gt (F) = 0.0366, wR ref (F 2) = 0.1043, T = 296(2) K.

C11H12O5, orthorhombic, P212121 (no. 19), a = 5.5523(7) Å, b = 12.7610(17) Å, c = 15.374(2) Å, V = 1089.3(2) Å3, Z = 4, R gt (F) = 0.0273, wR ref (F 2) = 0.0787, T = 296(2) K.

C9H15F6N2O2P, monoclinic, P21/n (no. 14), a = 8.3781(15) Å, b = 13.970(3) Å, c = 12.904(2) Å, β = 104.500(2)°, V = 1462.3(5) Å3, Z = 4, R gt (F) = 0.0677, wR ref(F 2) = 0.1977, T = 296(2) K.

C26H21Cl2F3N4O, monoclinic, Pc (no. 7), a = 21.218(6) Å, b = 5.9599(16) Å, c = 9.439(3) Å, β = 99.295(3)°, V = 1177.9(5) Å3, Z = 2, R gt (F) = 0.0471, wR ref (F 2) = 0.1282, T = 296(2) K.

C12H14O6, orthorhombic, Pbca (no. 61), a = 18.0207(13) Å, b = 7.6885(5) Å, c = 18.2326(13) Å, V = 2526.2(3) Å3, Z = 8, Rgt (F) = 0.0411, wRref (F 2) = 0.1214, T = 296(2) K.

C15H12N2O4, monoclinic, P21/c (no. 14), a = 5.4588(5) Å, b = 29.629(3) Å, c = 8.1217(8) Å, β = 93.157(1)°, V = 1311.6(2) Å3, Z = 4, R gt (F) = 0.0346, wR ref (F 2) = 0.0925, T = 296(2) K.

C16H18CdN4O8, monoclinic, P21/c (no. 14), a = 6.2751(4) Å, b = 21.7902(13) Å, c = 13.3401(8) Å, β = 90.793(1)°, V = 1823.89(19) Å3, Z = 4, R gt (F) = 0.0252, wR ref (F 2) = 0.0603, T = 296(2) K.

Five chalcone derivatives (E)-1-(2-(2-bromoethoxy)phenyl)-3-phenylprop-2-en-1-one(1), (E)-1-(2-(3-bromopropoxy)phenyl)-3-phenylprop-2-en-1-one(2),(E)-1-(2-(4-bromopropoxy)phenyl)-3-phenylprop-2-en-1-one(3),(E)-1-(2-(5-bromopropoxy)phenyl)-3-phenylprop-2-en-1-one(4),(E)-1-(2-(6-bromopropoxy)phenyl)-3-phenylprop-2-en-1-one(5) were synthesized and characterized by 1H NMR, HRMS. The crystalline structures of compounds 4 and 5 were further characterized by X-ray crystal diffraction. Among the five compounds, 1 and 2 showed inhibitory activity on α-glucosidase, but 4 and 5 increased the activity of α-glucosidase. Five chalcone derivatives were synthesized and characterized by 1H MNR and HRMS. The crystalline structures of two compounds were further characterized by X-ray crystal diffraction. Two of the compounds have the ability to inhibit α-glucosidase, and two different compounds have the ability to promote α-glucosidase.

2-(N-tert-butoxycarbonylamino) pyridine and 2-(N-tert-butoxycarbonylamino)-3-methylpyridine were synthesized in a one-step method using either 2-aminopyridine or 2-amino-3-methyphyridine with tert-butylcarbonyl anhydride as the starting materials. The products were characterized by single-crystal X-ray diffraction, 1H NMR, 13C NMR, and HRMS. The biological activity of the two compounds against five fungi was determined. 2-(N-tert-butoxycarbonylamino) pyridine has more than 50% inhibitory activity against Pyricularia oryzae, Colletotrichum gloeosporioides, and Alternaria alternate. In addition, the inhibitory activity of 2-(N-tert-butoxycarbonylamino)-3-methylpyridine against Alternaria alternate reached 67.69%. Two 2-BOC aminopyridine derivatives were synthesized and structurally characterized by 1H NMR, 13C NMR, HRMS analysis and X-ray crystal diffraction. The inhibitory activity both compounds was studied.

A facile and eco-friendly way for fabrication of CuO is developed based on an one-step chemical precipitation route without calcination procedure or use of surfactant. The structure features of as-prepared CuO are characterized by X-ray diffraction, scanning electron microscopy, transmission electron microscopy and N2 adsorption-desorption experiment. X-ray diffraction analysis shows that CuO with particle size of 13.5–19.2 nm and crystallinity of 67.0–72.9% can be fabricated by the transformation of Cu(OH)2 precursor at bath temperature above 50 °C. By adjusting the oil bath temperature and the content of ammonium hydroxide, we demonstrate a formation mechanism to control CuO to be 2D leaf-like structure with large specific surface area of 33.4 m2/g and pore volume of 0.226 cm3/g, or 3D flower-like ones with specific surface area of 7.45–18.7 m2/g and pore volume of 0.0249–0.0850 cm3/g. The catalytic performances of as-prepared CuO are evaluated by monitoring degradation of methylene blue in the presence of hydrogen peroxide. Almost 100% methylene blue degradation rate can be reached after reaction for 210 min on 3D flower-like CuO synthesized with 10 mL ammonia content in oil bath of 50 °C. The high activity can be correlated with the morphology and pore volume of CuO. The present synthetic strategy is an inexpensive and convenient way suitable for large-scale fabrication of copper oxides, which are potential catalysts for organic compounds degradation.

A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC50 values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC50 = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds 43, 40, and 34 were all competitive inhibitors on α-glucosidase with Kiof 10 µM, 52 µM, and 150 µM, respectively. Molecular docking demonstrated that the high active inhibitors interacted with α-glucosidase by four types of interactions, including hydrogen bonds, π–π stacking interactions, hydrophobic interactions, and electrostatic interaction. Among all the interactions, the π–π stacking interaction and hydrogen bond played a significant role in a various range of activities of the compounds.

C15H13F2NO4, monoclinic, P21/n (no. 14), a = 5.1342(10) Å, b = 9.6478(18) Å, c = 27.192(5) Å, β = 95.42°, V = 1340.9(4) Å3, Z = 4, R gt (F) = 0.0434, wR ref (F 2) = 0.1197, T = 296(2) K.

[C9H13F6N2O2P], monoclinic, P21/c (no. 14), a = 6.5994(13) Å, b = 10.754(2) Å, c = 19.754(4) Å, β = 96.267(2)°, V = 1393.6(5) Å3, Z = 4, R gt(F) = 0.0674, wR ref(F 2) = 0.2124, T = 296(2) K.

C18H16O8, monoclinic, P21/c (no. 14), a = 5.3210(8) Å, b = 5.1825(8) Å, c = 29.598(5) Å, β = 93.875(2)°, V = 814.3(2) Å3, Z = 2, R gt(F) = 0.0340, wR ref(F 2) = 0.1011, T = 296(2) K.

C18H12ClF2NO4, monoclinic, P21/c (no. 14), a = 13.544(5) Å, b = 9.344(3) Å, c = 13.545(5) Å, β = 109.86°, V = 1612.4(10) Å3, Z = 4, R gt(F) = 0.0393, wR ref(F 2) = 0.1058, T = 296(2) K.

[C16H12O4], monoclinic, P21/n (no. 14), a = 13.760(5) Å, b = 4.9003(18) Å, c = 19.125(7) Å, β = 101.331(5)°, V = 1264.5(8) Å3, Z = 4, R gt(F) = 0.0383, wR ref(F 2) = 0.1072, T = 296(2) K.

C11H18F12N4P2, monoclinic, P21/c (no. 14), a = 14.975(3) Å, b = 9.897(2) Å, c = 13.525(3) Å, β = 105.507(3)°, V = 1931.5(7) Å3, Z = 4, R gt(F) = 0.0590, wR ref(F 2) = 0.1843, T = 296(2) K.

C20H24O10, orthorhombic, P212121 (no. 19), a = 6.3728(6) Å, b = 14.3835(14) Å, c = 20.453(2) Å, V = 1874.8(3) Å3, Z = 4, R gt(F) = 0.0272, wR ref(F 2) = 0.0558, T = 296(2) K.

CuO/CeO2–MnO2 (CuCeMn-4) catalyst was prepared by redox method and was tested in the CO preferential oxidation in H2-rich gases (CO PROX). CuO/CeO2–Mn2O3 (CuCeMn-3) catalyst was prepared and tested for comparison. CuCeMn-4 exhibits higher catalytic activity than CuCeMn-3. The complete CO conversion with CO2 selectivity of 92% can be obtained at 120 °C over CuCeMn-4. The catalysts were characterized by means of N2 adsorption/desorption, XRD, H2-TPR and XPS techniques. The results show that the interaction between MnO2 and CeO2 in catalyst is stronger than Mn2O3 and CeO2, which can promote the mobility of oxygen species from CeO2–MnO2 to active copper species. XPS characterization further revealed that CuCeMn-4 contains richer lattice oxygen, higher amount of Cu+ species and less carbonate species on the surface as compared with CuCeMn-3. All these should be greatly responsible for the high activity of CuCeMn-4 catalyst.

A kind of functionalized diallylimidazole ionic liquids (CnDAIMF) was synthesized and applied in the dehydration of D-fructose to produce 5-HMF under the microwave radiation. The results showed that X-ray, 1H NMR and FT-IR confirmed the production. The target ILs existed in a highly centrally symmetric, and crystalline state at room temperature, with a good thermal stability up to 300°C (HTD≥340°C). In the experiments of conversion D-fructose to 5-HMF, 5-HMF could be obtained via the catalysis of diallylimidazole IL whether in water or DMSO. The catalytic performance of these ILs was not much different from that of solid acid (like camphor sulfonic acid or solid carbon sulfonic acid), and which was higher than that of the monoimidazole hexafluorophosphate or imidazole class bromine salt, but there were no obvious changes can be found with the variation of carbon chain length between imidazole rings in diallylimidazole IL. The effects of temperature and solvent on the reaction were more significant. The optimized yield of 5-HMF was 52.59% at 185°C in a water-C2DAIMF solvent (t=10 min), while 73.71% at 195°C in DMSO-C2DAIMF solvent. Furthermore, six CnDAIMF have a considerable effect on the conversion in water and 5-HMF yield of about 50% could be obtained, which is satisfactory compared with other similar processes, especially in the microwave system of aqueous solution. Therefore, this process may be benefit for many researches and applications related to functionalized ionic liquid research and biomass conversion applications.